Successful treatment of early acute antibody-mediated rejection in an human leukocyte antigen-incompatible and ABO-incompatible living-donor kidney transplant patient

For successful human leukocyte antigen-incompatible (HLAi) or ABO-incompatible (ABOi) living-donor kidney transplantations (LDKTs), pretransplant desensitization is essential; however, early antibody-mediated rejection (ABMR) remains the most important complication after HLAi or ABOi transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Gang, Sujin, Han, Ahram, Min, Sang-il, Ha, Jongwon, Yang, Jaeseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Transplantation 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188936/
https://www.ncbi.nlm.nih.gov/pubmed/35769976
http://dx.doi.org/10.4285/jkstn.2019.33.4.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188936/
https://www.ncbi.nlm.nih.gov/pubmed/35769976
http://dx.doi.org/10.4285/jkstn.2019.33.4.153

Ejemplares similares